Health Canada Warns Canadians Of New Safety Information Related To Long-term Use Of Azithromycin Following Stem Cell Transplants In Cancer Treatmen

Health Canada Safety Warning: Azithromycin and Cancer Treatment Health Canada has issued a warning about azithromycin (an antibiotic) used long-term after stem cell transplants in cancer patients, based on new safety information that has emerged. The warning applies to cancer patients across Canada who receive stem cell transplants and may be prescribed this medication during their recovery. Health Canada is alerting healthcare providers and patients to this safety concern related to extended use of this antibiotic in this specific medical context.

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2018-08-13

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/59ca4215-0b9c-43c9-9d18-3f5bc0f91788